VHCP Management II’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,874,602
| Closed | -$8.24M | – | 22 |
|
|
2019
Q3 | $8.24M | Hold |
2,874,602
| – | – | 3.14% | 8 |
|
|
2019
Q2 | $10.9M | Sell |
2,874,602
-374,562
| -12% | -$1.42M | 3.43% | 9 |
|
|
2019
Q1 | $26.4M | Hold |
3,249,164
| – | – | 7.74% | 6 |
|
|
2018
Q4 | $26.2M | Hold |
3,249,164
| – | – | 11.26% | 4 |
|
|
2018
Q3 | $24.8M | Buy |
3,249,164
+784,923
| +32% | +$5.99M | 6.62% | 6 |
|
|
2018
Q2 | $14.1M | Buy |
2,464,241
+243,270
| +11% | +$1.39M | 4.23% | 8 |
|
|
2018
Q1 | $10.6M | Sell |
2,220,971
-261,148
| -11% | -$1.25M | 2.56% | 12 |
|
|
2017
Q4 | $12.2M | Sell |
2,482,119
-683,338
| -22% | -$3.36M | 2.92% | 10 |
|
|
2017
Q3 | $16.6M | Buy |
3,165,457
+690,290
| +28% | +$3.62M | 4.58% | 6 |
|
|
2017
Q2 | $13.8M | Sell |
2,475,167
-3,595,975
| -59% | -$20M | 5.5% | 7 |
|
|
2017
Q1 | $51M | Hold |
6,071,142
| – | – | 20.87% | 2 |
|
|
2016
Q4 | $38.4M | Buy |
6,071,142
+350,000
| +6% | +$2.22M | 18.43% | 2 |
|
|
2016
Q3 | $25.2M | Hold |
5,721,142
| – | – | 12.95% | 2 |
|
|
2016
Q2 | $16.2M | Buy |
5,721,142
+1,031,707
| +22% | +$2.93M | 9.81% | 4 |
|
|
2016
Q1 | $13.3M | Buy |
+4,689,435
| New | +$13.3M | 8.73% | 4 |
|